Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-11-21
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0950-821X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
487-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1915918-Axillary Vein,
pubmed-meshheading:1915918-Dose-Response Relationship, Drug,
pubmed-meshheading:1915918-Fibrinolytic Agents,
pubmed-meshheading:1915918-Follow-Up Studies,
pubmed-meshheading:1915918-Heparin,
pubmed-meshheading:1915918-Humans,
pubmed-meshheading:1915918-Phlebography,
pubmed-meshheading:1915918-Thrombosis
|
pubmed:year |
1991
|
pubmed:articleTitle |
Heparin for axillary vein thrombosis.
|
pubmed:publicationType |
Letter,
Comment
|